about
Role of mTOR Inhibitors in Kidney DiseaseCostimulation Blockade in Kidney Transplantation: An UpdatemTOR function and therapeutic targeting in breast cancer.New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation.Neurologic Complications of Commonly Used Drugs in the Hospital Setting.New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.Mesenchymal stromal cells with enhanced therapeutic properties.Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus.Therapeutic Drug Monitoring on the Safety of Sirolimus in Transplant Patients.Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.The role of adjuvant immunomodulatory agents for treatment of severe influenza.Effects of rapamycin and curcumin treatment on the development of epilepsy after electrically induced status epilepticus in rats.A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.A Rapamycin-Activated Caspase 9-Based Suicide Gene.Determination of Immunosuppressive Pharmaceuticals in Whole Blood Following Kidney Transplantation by High-performance Liquid Chromatography–Tandem Mass Spectrometry
P2860
Q26747506-A3A72896-1149-4A8A-AA3C-CA52EB4C20F2Q37375148-810391E8-FAE4-4203-9115-78ECCBCB81DFQ37743486-A6D8B474-A52E-4D8D-BAAA-E700F93DA539Q38711763-9CD8A630-8B54-4C52-8804-FAA52EC0D2F8Q38746169-C3BF9E8E-D309-4435-B0FD-645F5DCB6082Q38849186-D832C91D-6D02-4445-B519-470B014F0B5DQ38962103-9765C086-79B0-42F6-88EC-2D7FACAE4ACDQ39045625-D069F7A7-C413-402F-B196-1985DBEC5B41Q42069171-4E6F8009-7226-4FD9-A1EF-959103C5459DQ42136015-D8092442-80F1-4873-8F46-2869E614BD21Q47351188-B664EEF7-152B-4DBD-B101-0AF3C67D1C62Q47554935-522CD30E-B68C-4137-88DA-5F40093FD8F3Q48872524-91B3350A-5310-4C04-9B2B-F83C055AEF16Q50148782-6CBC831B-BD2D-49C2-B184-5F717427B2DAQ52584838-C56EFADE-F4A4-4922-AEFD-A5CDC155C362Q58249481-3785591C-EB26-4572-B72E-7744D96F7FAE
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Sirolimus and everolimus in kidney transplantation.
@ast
Sirolimus and everolimus in kidney transplantation.
@en
type
label
Sirolimus and everolimus in kidney transplantation.
@ast
Sirolimus and everolimus in kidney transplantation.
@en
prefLabel
Sirolimus and everolimus in kidney transplantation.
@ast
Sirolimus and everolimus in kidney transplantation.
@en
P1433
P1476
Sirolimus and everolimus in kidney transplantation.
@en
P2093
Dirk Jan A R Moes
Johan W de Fijter
P304
P356
10.1016/J.DRUDIS.2015.05.006
P577
2015-06-04T00:00:00Z